Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-18-001710
Filing Date
2018-08-14
Accepted
2018-08-14 12:04:27
Documents
4
Period of Report
2018-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K correvio6k.htm 6-K 16254
2 NEWS RELEASE DATED AUGUST 14, 2018 ex991.htm EX-99.1 16711
3 GRAPHIC image_001.jpg GRAPHIC 706
4 PRINTER FRIENDLY VERSION ex991.pdf EX-99.1 60960
  Complete submission text file 0001279569-18-001710.txt   119429
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 181015577
SIC: 2834 Pharmaceutical Preparations